Insider Trading March 3, 2026

Alta Equipment CEO Disposes of $197K in Stock Following Recent Grants

Ryan Greenawalt sold nearly 28,000 shares after receiving PSUs and RSUs; Alta also posted a Q4 2025 beat while EPS remained negative

By Hana Yamamoto ALTG
Alta Equipment CEO Disposes of $197K in Stock Following Recent Grants
ALTG

Alta Equipment Group Inc. Chief Executive Officer Ryan Greenawalt sold 27,986 shares on March 3, 2026, for about $197,290 at a weighted average price of $7.0496. The disposition follows a February 27 grant of performance stock units and restricted stock units and comes amid a 58% year-to-date stock rally. Alta reported Q4 2025 results that beat expectations on both EPS and revenue, though EPS remained negative and the stock was unchanged in aftermarket trading.

Key Points

  • CEO Ryan Greenawalt sold 27,986 shares on March 3, 2026, for approximately $197,290 at a weighted average price of $7.0496; trades ranged from $7.02 to $7.14.
  • The sale occurred after Greenawalt received 72,832 PSUs and 115,837 RSUs on February 27, 2026 under Alta’s 2020 Omnibus Incentive Plan; he now directly holds 5,721,710 shares.
  • Alta reported Q4 2025 results that beat expectations - EPS of -$0.27 versus -$0.32 forecast, and revenue of $509 million versus $489.56 million expected - yet the stock was unchanged in aftermarket trading.

Alta Equipment Group Inc. (NASDAQ: ALTG) said Chief Executive Officer Ryan Greenawalt executed a sale of 27,986 shares of common stock on March 3, 2026, generating approximately $197,290. The transaction carried a weighted average sale price of $7.0496, with the individual trades ranging from $7.02 to $7.14.

The stock has rallied strongly year-to-date, gaining roughly 58% and trading at $7.29 around the time of the reported sale.

This sale followed a recent award under the company’s 2020 Omnibus Incentive Plan. On February 27, 2026, Greenawalt was granted 72,832 shares as performance stock units (PSUs) and 115,837 shares as restricted stock units (RSUs). The March 3 disposal occurred after those grants were recorded.

After completing the March 3 transaction, Greenawalt directly holds 5,721,710 shares of Alta Equipment Group common stock.


Earnings context

Alta Equipment Group also disclosed fourth-quarter 2025 financial results that topped analyst expectations. The company reported earnings per share of -$0.27, outperforming the forecasted -$0.32. Revenue for the quarter came in at $509 million versus an anticipated $489.56 million, representing a revenue surprise of approximately 3.99%.

Despite the upside versus consensus on both EPS and revenue, the company’s share price was reported as unchanged in aftermarket trading following the release.


What this shows

The sequence of events recorded by the company includes a compensation-related grant at the end of February, a subsequent insider sale in early March, and a quarterly report that beat expectations on both the top and bottom lines, though EPS remains negative on a per-share basis. Market reaction in the immediate aftermarket was muted.

Note on limitations

All figures and dates presented above are those reported by the company. The article is limited to the information provided in those disclosures and does not attempt to interpret internal motivations or future stock performance beyond the stated results.

Risks

  • Despite beating consensus on EPS and revenue for Q4 2025, Alta’s EPS remained negative at -$0.27, highlighting continued unprofitability on a per-share basis - impacts investors in the industrials and equipment sectors.
  • Market response to the quarterly beat was muted, with the share price unchanged in aftermarket trading, creating uncertainty in capital markets about the sustainability of the recent rally.
  • The insider sale occurred soon after the grant of PSUs and RSUs on February 27, 2026, introducing timing-related uncertainty for observers assessing insider activity and executive compensation.

More from Insider Trading

Acumen Pharmaceuticals CLO Executes 9,406-Share Sale Under 10b5-1 Plan; Exercises Matching Options Mar 3, 2026 Revolution Medicines Director Disposes $3.64 Million in Stock; Exercises Options Amid Mixed Analyst Views Mar 3, 2026 Arlo CFO Disposes $187K in Shares Amid Recent Rally Mar 3, 2026 Arlo Technologies CEO Completes $416,959 Stock Sale as Company Posts Q4 Beat Mar 3, 2026 EverCommerce CEO Executes $219,363 Share Sale; Analysts Trim Ratings for Related Software Names Mar 3, 2026